Jing Yan

Jing Yan currently serves as the Senior Director of Research at FundaMental Pharma, focusing on lead optimization of N/T interface inhibitors, mode of action, target engagement, and biomarkers since November 2022. Additionally, Jing Yan has been involved with the University of Heidelberg since September 2014, taking on roles such as Guest Scientist, Akademischer Rat auf Zeit, and Postdoctoral Researcher, following a PhD in Neurobiology obtained from Heidelberg University in 2020. Earlier academic achievements include a Master of Science in Cell/Cellular and Molecular Biology from Shandong University in 2013 and a Bachelor of Science in Biotechnology from the same institution in 2010.